Final results from a phase 1/2, 48-month, open-label extension study of givosiran in patients with acute intermittent porphyria
Journal of Hepatology(2023)
关键词
givosiran,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Hepatology(2023)